FAD

FLAVIN-ADENINE DINUCLEOTIDE


View summary at Ligand Expo



Chemical Component Summary

NameFLAVIN-ADENINE DINUCLEOTIDE
Identifiers[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentoxy]-hydroxy-phosphoryl] hydrogen phosphate
FormulaC27 H33 N9 O15 P2
Molecular Weight785.55
TypeNON-POLYMER
Isomeric SMILESCc1cc2N=C3C(=O)NC(=O)N=C3N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc6c(N)ncnc56)c2cc1C
InChIInChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1
InChIKeyVWWQXMAJTJZDQX-UYBVJOGSSA-N

Chemical Details

Formal Charge0
Atom Count86
Chiral Atom Count9
Bond Count91
Aromatic Bond Count16

Drug Info: DrugBank

DrugBank IDDB03147 
NameFlavin adenine dinucleotide
Groupsapproved
DescriptionA condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972) Flavin adenine dinucleotide is approved for use in Japan under the trade name Adeflavin as an ophthalmic treatment for vitamin B2 deficiency.
Synonyms
  • Flavine adenine dinucleotide
  • Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine
  • adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]
  • Flavin adenine dinucleotide disodium
  • Flavin adenine dinucleotide
Brand Names
  • PramLyte
  • EnBrace HR
  • EnLyte
  • BumP DHA
IndicationUsed to treat eye diseases caused by vitamin B2 deficiency, such as keratitis and blepharitis.
Categories
  • Adenine Nucleotides
  • Biological Factors
  • Carbohydrates
  • Coenzymes
  • Enzymes and Coenzymes
CAS number146-14-5

Drug Targets

NameTarget SequencePharmacological ActionActions
UDP-galactopyranose mutaseMYDYIIVGSGLFGAVCANELKKLNKKVLVIEKRNHIGGNAYTEDCEGIQI...unknown
FlavohemoproteinMLTQKTKDIVKATAPVLAEHGYDIIKCFYQRMFEAHPELKNVFNMAHQEQ...unknown
Glycine oxidaseMKRHYEAVVIGGGIIGSAIAYYLAKENKNTALFESGTMGGRTTSAAAGML...unknown
NADPH--cytochrome P450 reductaseMGDSHVDTSSTVSEAVAEEVSLFSMTDMILFSLIVGLLTYWFLFRKKKEE...unknown
Glutaryl-CoA dehydrogenase, mitochondrialMALRGVSVRLLSRGPGLHVLRTWVSSAAQTEKGGRTQSQLAKSSRPEFDW...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem643975
ChEBICHEBI:16238
ChEMBLCHEMBL1232653